Update

ACT-AD-Sponsored Study Reveals Differences in the Way FDA Reviews Potential AD, HIV/AIDS, and Cancer Therapies.

June 5, 2007
An ACT-AD-sponsored study by Avalere Health revealed differences in the way the FDA reviews potential Alzheimer’s disease, HIV/AIDS, and cancer therapies.
See Press Release

File Attachments
  avalere_6-5-20071 (40K PDF)
Categories:
Uncategorized